You are on page 1of 50

Cardiac Diseases in

Pregnancy

• Dr.Uma Gupta MD,FICMCH


• Dr.N.K.Gupta MS,MCh
umankgupta@yahoo.com
drnkgupta2000@yahoo.com
08/01/09 Dr.Uma Dr.NK Gupta 1
The incidence and changing
pattern of heart disease

• It ranges from 0.1% to 4%.


• Hospital statistics - industrialized
countries have shown a decrease in
the incidence from 0.9% to 0.3%

08/01/09 Dr.Uma Dr.NK Gupta 2


Incidence of heart disease………

Sharp decline in the incidence of chronic


rheumatic heart disorders.

Advances in the medical and surgical


treatment of patients with congenital heart
defects has resulted in an increased
survival to reproductive age.

08/01/09 Dr.Uma Dr.NK Gupta 3


Maternal mortality from heart
disease
• Statistics have demonstrated a decline in
maternal mortality from cardiac disease
since 1950 from 5.6 to 0.3 per 100 000
births.
• B’s of improved medical care of the
pregnant cardiac patient and a sharp
decrease in the incidence of rheumatic
heart disease.

08/01/09 Dr.Uma Dr.NK Gupta 4


Maternal mortality from heart disease

• Confidential enquiry of latest report on maternal


deaths in the United Kingdom, has shown that
cardiac disease accounted for the greatest
number of maternal deaths
• accounting for 35 (16.5%) of all maternal deaths
over the period 1997–99*
• (37 of 323) in the 1991 to 1993 triennium
• (18) -1988 to 1990 trienniums
• (23) -1985 to 1987
* de Swiet M. Cardiac disease. In: Lewis G, Drife J, eds. Why Mothers Die 1997–1999. The Confidential Enquiries into Maternal Deaths in the United

Kingdom. London: Royal College of Obstetricians and Gynaecologists, 2001; 153–64

08/01/09 Dr.Uma Dr.NK Gupta 5


Maternal mortality from heart disease

Cardiac diseases is also the leading


cause of indirect maternal death. Of
the cardiac deaths reported to the
Confidential enquiry between 2000-
2002, 40% were noted to have
substandard care.

Deans CL, Uebing A, Steer PJ. Cardiac disease in pregnancy. In Progress in


Obstetrics and Gynaecology, Vol 17, Edi Studd J, Tan S L, Chervenak FA.Churchill
Livingstone 2007, 164-182.

08/01/09 Dr.Uma Dr.NK Gupta 6


Cardiovascular Physiology of
Pregnancy

• Normal pregnancy is associated with an


increase of 30 to 50 percent in blood volume
• Blood volume increases, starting at the sixth
week and rising rapidly until mid pregnancy; the
levels peak by 20 to 24 weeks of pregnancy and
then are either sustained until term or decrease
An estrogen-mediated stimulation of the renin-
angiotensin system results in sodium and water retention
appears to be the mechanism underlying the blood
volume increase.
08/01/09 Dr.Uma Dr.NK Gupta 7
Cardiovascular Physiology of
Pregnancy
• Increase in cardiac output is most significant
change during pregnancy.
• It begins to rise in first trimester and steadily
rises to peak at 32 weeks by 30 to 50%.
• Cardiac output is normally 4.2 L/min., is 6.5
L/min. at 8-10 weeks of pregnancy and remains
so till near term.
• Increase in cardiac output is achieved by rise in
stroke volume (in early pregnancy) and Heart
Rate (in latter part of pregnancy) adjusting
together

08/01/09 Dr.Uma Dr.NK Gupta 8


Cardiovascular Physiology of Pregnancy

• Due to rise in endogenous circulating


catecholamine, there is positive inotropic and
chronotropic myocardial response.

• Later in pregnancy, the rise is related to an


acceleration of heart rate (25%), since stroke
volume decreases as a result of vena caval
compression.

08/01/09 Dr.Uma Dr.NK Gupta 9


08/01/09 Dr.Uma Dr.NK Gupta 10
• Blood Pressure remains almost to
prepregnant levels except a tendency to
fall during pregnancy (particularly during
midtrimester) as the systemic
vascular/peripheral resistance falls
(due to large arteriovenous shunts at
placental bed and physiologic vasodilation
secondary to endothelial prostacyclin and
circulating progesterone)

08/01/09 Dr.Uma Dr.NK Gupta 11


• Colloid oncotic pressure is another
important variable
• Both plasma and interstitial colloid oncotic
pressure decrease throughout pregnancy
• There is accompanying increase in
capillary hydrostatic pressure.
• An increase in hydrostatic pressure or a
decrease in colloid oncotic pressure may
overcome the delicate balance that favors
oedema formation

08/01/09 Dr.Uma Dr.NK Gupta 12


Colloid oncotic pressure
• After delivery, decrease in plasma colloid
oncotic pressure takes place reaching a
peak between 6 to 16 hours and returns
towards intrapartum level after 24 hours.
• These changes can lead to dependant
oedema complicating diagnosis of cardiac
decompensation.

08/01/09 Dr.Uma Dr.NK Gupta 13


Simulating cardiac disease
Owing to these normal changes, many
healthy pregnant women have symptoms
mimicking those of cardiac disease,
Including:
fatigue, dyspnea, and light-headedness,
& number of “abnormal” findings on physical
examination, electrocardiography, and
echocardiography
08/01/09 Dr.Uma Dr.NK Gupta 14
Table 1. Normal physiological changes of pregnancy
that mimic symptoms and signs of cardiac disease
Symptoms
Tiredness
Dyspnoea
Orthopnoea
Syncope
Light-headedness
Physical signs
Peripheral oedema
Hyperventilation
Distended neck veins with prominent A and V
waves
Brisk, diffuse, and displaced left ventricular
impulse
Palpable right ventricular impulse
Increased S1 intensity
Persistent splitting of S2
Early ejection systolic murmurs at lower left
sternal edge or pulmonary area
08/01/09 Cervical venous
Dr.Umahum
Dr.NK Gupta 15
Mammary souffle
Contd..
Table 1. Normal physiological changes of pregnancy
that mimic symptoms and signs of cardiac disease

Electrocardiogram
Left axis deviation
ST segment and T wave changes
Small Q, inverted P or T wave in lead III
Increased R wave amplitude in lead V2
Atrial or ventricular ectopics
Chest X-ray
Straightened left upper cardiac border
Horizontal heart position
Increased lung markings
Echocardiogram
Increased left/right ventricular dimensions
Mild increase in left/right atrial size
Slightly improved left ventricular systolic function
Functional tricuspid/pulmonary insufficiency
08/01/09 Small pericardial
Dr.Uma effusion
Dr.NK Gupta 16
Management areas
Areas be considered in the clinical approach to
the woman with heart disease who is pregnant
or considering pregnancy:
2) Risk stratification, Pre-conceptional
3) Antepartum management,
4) Peripartum management,
4) Recurrence of congenital lesion in the neonate,
5) Site of antepartum and peripartum care.

08/01/09 Dr.Uma Dr.NK Gupta 17


Pre-conceptional counselling
• This is an important aspect of
management or the cardiac patient
planning a pregnancy.
• Ideally, the obstetrician and cardiologist
should work together to help the patient
make an informed decision.
• Prevent an unwanted pregnancy and
avoid the risks associated with pregnancy
continuation or termination.
08/01/09 Dr.Uma Dr.NK Gupta 18
Risk assessment
• Poor functional status (NYHA class III or
IV) or cyanosis
• Left ventricular systolic dysfunction (ejection
fraction < 0.40)
• Left heart obstruction (mitral valve area
<2.0 cm2, aortic valve area < 1.5 cm2, or
peak left ventricular outflow tract gradient
> 30 mm Hg)

08/01/09 Dr.Uma Dr.NK Gupta 19


Risk assessment
A cardiac event (arrhythmia, stroke,
transient ischemic attack, or
pulmonary edema) before pregnancy
but since a prior cardiac surgical
procedure.

08/01/09 Dr.Uma Dr.NK Gupta 20


Risk assessment
Siu developed a risk index incorporating
these factors.
In a woman with heart disease and no other risk
factors, the likelihood of a cardiac event during
pregnancy is about 5%, increasing to 25% with one
risk factor & 75% with more than one risk factor.

Siu SC, Sermer M, Colman JM, et al. Prospective multicenter


study of pregnancy outcomes in women with heart disease.
Circulation 2001; 104:515–521.

08/01/09 Dr.Uma Dr.NK Gupta 21


Table 2. Maternal mortality risk and cardiac disease
Group Cardiac disease Associated mortality risk
I Atrial septal defect* <1%
Ventricular septal defect*
Patent ductus arteriosus*
Pulmonary/tricuspid valve disease
Corrected tetralogy of Fallot
Bioprosthetic valve
Mitral stenosis, NYHA Class I, II
II Coarctation of aorta without valvular involvement 5% - 15%
Uncorrected tetralogy of Fallot
Marfan’s syndrome with normal aorta
Mechanical prosthetic valve
Mitral stenosis with atrial fibrillation or NYHA Class III, IV
Aortic stenosis
Previous myocardial infarction
III Pulmonary hypertension—primary or secondary 25% - 50%
Coarctation of aorta with valvular involvement
Marfan’s syndrome with aortic involvement
Peripartum cardiomyopathy
*Uncomplicated
08/01/09 Dr.Uma Dr.NK Gupta 22
• A careful history is obtained to identify
previous cardiac complications.
• The patients functional status as per The
New York Heart Association(NYHA) is
defined

08/01/09 Dr.Uma Dr.NK Gupta 23


Table 3.NEW YORK HEART ASSOCIATION FUNCTIONAL
CLASSIFICATION OF CARDIAC DISEASE

CLASS I No functional limitation of activity.


No symptoms of cardiac decompensation with activity.

CLASS II Mild amount of functional limitation.


Patients are asymptomatic at rest. Ordinary physical activity
results in symptoms.

CLASS III Limitation of most physical activity.


Asymptomatic at rest
Minimal physical activity results in symptoms.

CLASS IV Severe limitation of physical activity results in symptoms.


Patients may be symptomatic at rest/heart failure
at any point of pregnancy.

CLASS V If patient is on ionotropic support, ventilator, Assisted


circulation or having comprised renal or pulmonary
function necessitating dialysis/EMCO to
maintain vital signs.

The criteria committee of the New York Heart Association, Nomenclature and criteria for diagnosis of diseases of heart and great vessels,
Edi 8, New York Association,1979.
08/01/09 Dr.Uma Dr.NK Gupta 24
Antepartum Care

• The chief aim of management of the


patient in pregnancy is to keep patient
within her cardiac reserve.
• It is preferable to have detailed baseline
information prior of pregnancy.

08/01/09 Dr.Uma Dr.NK Gupta 25


Antepartum care
• Limiting activity is helpful in severely
affected women with ventricular
dysfunction,
• left heart obstruction, or class III or IV
symptoms.
• Hospital admission by mid-second
trimester may be advisable for some.

08/01/09 Dr.Uma Dr.NK Gupta 26


Antepartum care
• Problems should be identified early
and treated aggressively, especially
pregnancy induced hypertension,
hyperthyroidism, infection, and anemia.

08/01/09 Dr.Uma Dr.NK Gupta 27


Table 4. Recommended antibiotic prophylaxis for high-risk women undergoing
genitourinary or gastrointestinal procedures
Category Drug and dosage

High-risk patient Ampicillin, 2 g IM or IV,


plus
gentamicin sulfate (Garamycin), 1.5 mg/kg IV 30 min before
procedure; ampicillin, 1 g IV, or amoxicillin (Amoxil,
Trimox, Wymox), 1 g PO 6 hr after procedure

High-risk patient Vancomycin HCl (Vancocin, Vancoled), 1 g IV over 2 hr,


who has plus
penicillin allergy gentamicin sulfate, 1.5 mg/kg IV 30 min before procedure

08/01/09 Dr.Uma Dr.NK Gupta 28


08/01/09 Dr.Uma Dr.NK Gupta 29
Antepartum care

Beta-blockers rather than digoxin should be used to


control the heart rate for patients with functionally
significant mitral stenosis.

Empiric therapy with beta-blockers is offered


to patients with coarctation, Marfan syndrome,
and ascending aortopathy for other reasons (eg, a
bicuspid aortic valve).

08/01/09 Dr.Uma Dr.NK Gupta 30


Arrhythmias should be treated if warranted

Premature atrial or ventricular beats are common


in normal pregnancy, and in patients with
preexisting arrhythmias,

Pregnancy may exacerbate their frequency and


hemodynamic severity.

These usually are not treated.

08/01/09 Dr.Uma Dr.NK Gupta 31


Antepartum care
Sustained tachyarrhythmias, such as
atrial flutter or atrial fibrillation, should be
treated promptly.

If possible, all antiarrhythmic drugs should


be avoided during the first trimester, and those
known to be teratogenic should be avoided
throughout pregnancy.

Because of their safety profiles, preferred drugs


include digoxin, beta-blockers and adenosine.

08/01/09 Dr.Uma Dr.NK Gupta 32


08/01/09 Dr.Uma Dr.NK Gupta 33
Antepartum care

• Anticoagulation therapy. No current


strategy is equally safe for both mother
and fetus.

08/01/09 Dr.Uma Dr.NK Gupta 34


Anticoagulation therapy
Oral therapy with warfarin is effective and
logistically easy.
However, it can affect embryonic organ
development, although some evidence shows
that a dosage of 5 mg per day may not be
teratogenic.
Fetal intracranial bleeding is a risk throughout
pregnancy, particularly during vaginal delivery,
unless warfarin is stopped before labor.

08/01/09 Dr.Uma Dr.NK Gupta 35


Anticoagulation therapy
* Heparin in adjusted subcutaneous doses
does not cross the placenta and so has no
teratogenic effects.

However, it may cause maternal


thrombocytopenia and osteoporosis and is
less effective in preventing thrombosis in
patients with prosthetic valves.
08/01/09 Dr.Uma Dr.NK Gupta 36
Anticoagulation therapy
More recent guidelines recommend either
(1) adjusted-dose heparin during the entire pregnancy or

(2) adjusted-dose heparin until the 13th week of gestation,


warfarin from the 14th week to the middle of the third
trimester, and then restart adjusted-dose heparin.
* Low-molecular-weight heparin in adjusted
doses is easier to administer and has been
suggested as an alternative to adjusted-dose
unfractionated heparin.

Bates SM, Greer IA, Hirsh J, Ginsberg JS. Use of antithrombotic agents during pregnancy. Chest 2004; 126:627S–

644S
08/01/09 . Dr.Uma Dr.NK Gupta 37
Anticoagulation therapy
At week 36 #
*Discontinue warfarin
*Change to UFH titrated to a therapeutic aPTT or anti-
factor Xa level.
At Delivery:
*Restart heparin therapy 4 to 6 hr after delivery if no
contraindications
*Resume warfarin therapy the night after delivery if no
bleeding complications
#if labor begins while the woman is receiving warfarin,
anticoagulation should be reversed and caesarean
delivery performed
Ginsberg JS, Greer I, Hirsh J. Use of antithrombotic agents during pregnancy. Chest 2001;119:Suppl:122S-131S

08/01/09 Dr.Uma Dr.NK Gupta 38


Anticoagulation therapy
Monitoring
• With LMWH administered sc. twice daily
maintain anti-Xa level between 0.7 and
1.2 U/ml 4 hours after admn.
• With dose adjusted UFH, the aPTT should be at
least twice control.
• those on warfarin, the INR goal should be
3.0(range 2.5 to 3.5)
Chan WS, Anand S, Ginsberg JS. Anticoagulation of pregnant women with mechanical heart valves: a systematic

review of the literature. Arch Intern Med 2000;160:191-196

08/01/09 Dr.Uma Dr.NK Gupta 39


Peripartum management
• Cesarean section is indicated only for the
following conditions:
• Aortic dissection
• Marfan syndrome with dilated aortic root
• Taking warfarin within 2 weeks of labor.

08/01/09 Dr.Uma Dr.NK Gupta 40


Peripartum care

Preterm induction is uncommon.


However, once fetal lung maturity is
assured,

a planned induction and delivery may be


warranted for high-risk patients to ensure
that appropriate staff and equipment are
available.

08/01/09 Dr.Uma Dr.NK Gupta 41


Peripartum care
Antibiotic prophylaxis for endocarditis is
not routine. AHA guidelines do not recommend routine
endocarditis prophylaxis for cesarean section delivery or
for uncomplicated vaginal delivery without infection.37

However, some centers do administer


endocarditis prophylaxis for vaginal delivery
in women with structural heart disease, as an
uncomplicated delivery cannot always be
anticipated.

08/01/09 Dr.Uma Dr.NK Gupta 42


Peripartum care

Positioning the patient on her left


side
lessens the hemodynamic fluctuations
associated with contractions when the
patient is supine.

08/01/09 Dr.Uma Dr.NK Gupta 43


Peripartum care

• Forceps or vacuum extraction should be


considered at the end of the second stage
of labor to shorten and ease delivery.

08/01/09 Dr.Uma Dr.NK Gupta 44


Peripartum care

• Postpartum monitoring

Because hemodynamics do not return to


baseline for many days after delivery,
patients at intermediate or high risk may
require monitoring for at least 72 hours
postpartum.

08/01/09 Dr.Uma Dr.NK Gupta 45


Peripartum care

• Lactation should be encouraged unless


patient is in failure.
• Cardiac output is not compromised during
lactation.
• Lactation is a pathway for fluid excretion
and diuretic requirement may actually fall.

08/01/09 Dr.Uma Dr.NK Gupta 46


Contraception
• Barrier methods – unreliable.
• COC contraindicated.
• Progesterone only pill have better side effect
profile & long acting slow releasing as Mirena
intrauterine system have improved efficacy.
• Sterilization where family completed.
(Laparoscopic clip sterilization carries risk).
Deans CL, Uebing A, Steer PJ. Cardiac disease in pregnancy. In Progress in Obstetrics and Gynaecology, Vol 17, Edi Studd J, Tan S L,

Chervenak FA.Churchill Livingstone 2007, 164-182.

08/01/09 Dr.Uma Dr.NK Gupta 47


Conclusion
Pregnancy causes significant haemodynamic
changes and imposes an additional burden on
the cardiac patient, especially around the time of
labour and in the immediate puerperium.

To achieve a successful pregnancy outcome, a


clear understanding of these haemodynamic
adaptations as well as meticulous maternal and
foetal surveillance for risk factors and
complications throughout the pregnancy is
essential.
08/01/09 Dr.Uma Dr.NK Gupta 48
Conclusion
Appropriate contraceptive and family planning
advice as well as pre-conceptional counselling
are also important.
The concerted efforts of a team consisting of the
obstetrician, cardiologist, anaesthetist,
cardiothoracic surgeon, neonatologist, and
paediatric cardiologist are mandatory to ensure
optimal results.

08/01/09 Dr.Uma Dr.NK Gupta 49


08/01/09 Dr.Uma Dr.NK Gupta 50